Monoclonal antibody combination specifically recognizing hemagglutinin protein of avian influenza virus h6 subtype and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING SUBENYUANHE BIOTECHNOLOGY CO LTD
- Filing Date
- 2026-04-29
- Publication Date
- 2026-05-29
AI Technical Summary
Existing detection methods for the H6 subtype of avian influenza virus suffer from cross-reactivity interference, leading to false positives and making it difficult to achieve a balance between specificity and sensitivity. In particular, there is a lack of effective means in field screening and epidemiological surveillance.
A combination of monoclonal antibodies that specifically recognize the hemagglutinin protein of the H6 subtype of avian influenza virus, including monoclonal antibodies 2D12 and 4G3, was used to construct colloidal gold test strips targeting different epitopes for rapid and convenient in vitro detection.
It improves the accuracy and sensitivity of detection, avoids cross-reaction with other influenza subtypes such as H1, H5, H7, and H9, as well as common avian pathogens, and is suitable for on-site screening and early detection of H6 subtype avian influenza virus.
Smart Images

Figure CN122103323A_ABST